title: Advances in antibacterial therapy.
abstract: Bacterial resistance is still a major concern in antibiotic therapy, especially for immunocompromised and transplantation patients. New therapeutic options are, therefore, needed to overcome the onset of antibiotic resistance. This article reviews the potential role of some antibiotics recently marketed or in clinical development, with a focus on their potential use in transplant recipients.
authors.affiliation: Department of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. rmoeller@bidmc.harvard.edu
authors.forename: R C
authors.initials: RC
authors.lastname: Moellering
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016377:Organ Transplantation / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents